Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today ...
A new proposal to enhance car-free California Avenue with planters, road improvements and a playful "modern optimism" ...
Barclays analyst Saket Kalia maintained a Buy rating on nCino (NCNO – Research Report) today and set a price target of $44.00. The company’s ...
Barclays analyst Saket Kalia maintained a Hold rating on Fortinet (FTNT – Research Report) today and set a price target of $103.00. The ...
14h
AI and automation integration and government initiatives offer remunerative opportunities for the expansion of the global zero trust architecture market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback